Novo Nordisk eyes bolt-on deals as pipeline disappointments pile up
“If you don't like setbacks and you don't like failure, don't get into the pharma industry,” Novo Nordisk CEO Maziar Mike Doustdar said on a call with media Wednesday. The implication was unintended, but anyone ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.